Switch to:
More From Other Websites
Avanir Pharmaceuticals Announces FDA Approval of ONZETRA™ Xsail™ (AVP-825) for the Acute... Jan 28 2016
Avanir Pharmaceuticals Announces Appointment of Rohan Palekar as President and Chief Executive... Jan 20 2016
Avanir Pharmaceuticals Announces Initiation of Phase III Trial of AVP-786 for Agitation in Patients... Dec 10 2015
Avanir Pharmaceuticals Announces Publication of Study Evaluating the Prevalence of Pseudobulbar... Dec 01 2015
Concert Pharmaceuticals Achieves $2 Million Milestone from Avanir Pharmaceuticals for Phase 3... Nov 16 2015
Avanir Pharmaceuticals Announces Initiation of Phase III Trial of AVP-786 for Agitation in Patients... Nov 16 2015
Avanir Pharmaceuticals Announces JAMA Publication of Phase II Study Results Showing AVP-923... Sep 22 2015
Avanir Pharmaceuticals Announces JAMA Publication of Phase II Study Results Showing AVP-923... Sep 22 2015
Avanir Pharmaceuticals Prevails in NUEDEXTA® Patent Appeal Maintaining Exclusivity Through 2026 Aug 11 2015
Avanir Pharmaceuticals Prevails in NUEDEXTA® Patent Appeal Maintaining Exclusivity Through 2026 Aug 11 2015
Avanir Pharmaceuticals Announces New Findings from Dementia/Alzheimer's Disease Cohort of PRISM II... Jul 23 2015
Avanir Pharmaceuticals Announces New Findings from Dementia/Alzheimer's Disease Cohort of PRISM II... Jul 23 2015
/C O R R E C T I O N -- Avanir Pharmaceuticals, Inc./ Jun 30 2015
/C O R R E C T I O N -- Avanir Pharmaceuticals, Inc./ Jun 30 2015
Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II... Jun 30 2015
Avanir Pharmaceuticals Announces Publication of Positive Phase IIIb Results from AVP-825... Jun 17 2015
Avanir Pharmaceuticals Announces Publication of Positive Phase IIIb Results from AVP-825... Jun 17 2015
Avanir Pharmaceuticals Announces Presentation of Survey Evaluating the Prevalence of Pseudobulbar... May 05 2015
Avanir Pharmaceuticals Announces Presentation of Survey Evaluating the Prevalence of Pseudobulbar... May 05 2015
Danny Glover Joins PBA Facts Campaign, to Educate and Build Awareness of Pseudobulbar Affect (PBA),... May 01 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK